Treatment

MMB clinical trials

1 indexed studies · 0 currently recruiting

Active not recruitingPHASE2
Extended Access of Momelotinib in Adults With Myelofibrosis
This study offers ongoing access to a medication called momelotinib for adults with myelofibrosis. It checks how safe the medicine is long-term and tracks its effects on survival for those already taking part in specific earlier studies and benefiting from the treatment.
For: Neoplasms · Post-polycythemia Vera Myelofibrosis (Post-PV MF) · Primary Myelofibrosis (PMF)
United States · Australia · Austria